```json
{
"content": [
{
"type": "paragraph",
"content": "North America dominates the Immune Support Gummies market, accounting for 35% of global revenue, driven by high consumer adoption of preventive healthcare, robust R&D investments, and a mature wellness ecosystem. The aging population and rising health-conscious millennials further propel demand."
},
{
"type": "paragraph",
"content": "Europe follows with 30% market share, fueled by regulatory support for natural supplements, growing interest in holistic wellness, and strong e-commerce infrastructure. Germany and the UK lead in adoption, supported by favorable policies and high disposable incomes."
},
{
"type": "paragraph",
"content": The Asia Pacific region emerges as the fastest-growing market, projected to expand at a CAGR of 12% through 2030. Urbanization, rising middle-class disposable incomes, and increasing health awareness in India and China are key drivers. However, fragmented regulations and infrastructure gaps moderate growth."
},
{
"type": "paragraph",
"content": "Latin America captures 8% of the market, with Brazil and Mexico showing traction due to rising social media influence on health trends. Infrastructure challenges and economic volatility, however, hinder broader adoption."
},
{
"type": "paragraph",
"content": "The Middle East & Africa region, at 2% share, remains underdeveloped but shows potential. Improved healthcare infrastructure in South Africa and growing e-commerce access could accelerate Immune Support Gummies market growth in the long term."
}
],
"worldMapData": {
"regions": [
{ "name": "North America", "value": 35 },
{ "name": "Europe", "value": 30 },
{ "name": "Asia Pacific", "value": 25 },
{ "name": "Latin America", "value": 8 },
{ "name": "Middle East & Africa", "value": 2 }
]
}
}
```
